Vineet Laboratories Yönetim

Yönetim kriter kontrolleri 1/4

Şu anda CEO hakkında yeterli bilgiye sahip değiliz.

Anahtar bilgiler

İcra Kurulu Başkanı

n/a

Toplam tazminat

CEO maaş yüzdesi	n/a
CEO görev süresi	no data
CEO sahipliği	n/a
Yönetim ortalama görev süresi	Veri yok
Yönetim Kurulu ortalama görev süresi	3.8yrs

Son yönetim güncellemeleri

Recent updates

CEO

Vineet Laboratories CEO'su yok ya da onlar hakkında elimizde veri yok.

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Gaddam Ramana	Founder	3.8yrs	₹5.10m	14.95% ₹ 69.3m
Satyanarayana Bhupathiraju	CFO & Whole-time Director	3.8yrs	₹3.90m	5.63% ₹ 26.1m
Hari Yerukalapudi	Non-Executive Independent Director	2.3yrs	₹125.00k	Veri yok
Alluri Raju	Non-Executive Director	1.3yrs	₹75.00k	2.08% ₹ 9.7m
Dilip Acharekar	Independent Non-Executive Chairman	4yrs	₹125.00k	Veri yok

3.8yrs

Ortalama Görev Süresi

56yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: 543298 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 3.8 yıldır).

Vineet Laboratories Yönetim

Yönetim kriter kontrolleri 1/4

Anahtar bilgiler

Son yönetim güncellemeleri

Less than half of directors are independent

Vineet Laboratories Limited Announces Resignation of Bhaskara Reddy Karna as Independent Director

Vineet Laboratories Limited, Annual General Meeting, Sep 27, 2024

Vineet Laboratories Limited Announces Resignation of Satish Pandurang Samant as Executive Director

Vineet Laboratories Limited Announces Appointment of Mr. Rameshkumar Bandari as Company Secretary and Compliance Officer

Vineet Laboratories Limited Announces Resignation of Nirosha Ravikanti as Company Secretary / Compliance Officer of the Company

Recent updates

Less than half of directors are independent

Second quarter 2025 earnings released: ₹1.98 loss per share (vs ₹2.62 profit in 2Q 2024)

Vineet Laboratories Limited Announces Resignation of Bhaskara Reddy Karna as Independent Director

Vineet Laboratories Limited to Report Q2, 2025 Results on Nov 13, 2024

Vineet Laboratories Limited, Annual General Meeting, Sep 27, 2024

First quarter 2025 earnings released: ₹2.31 loss per share (vs ₹1.36 loss in 1Q 2024)

Vineet Laboratories Limited to Report Q1, 2025 Results on Aug 13, 2024

Investor sentiment improves as stock rises 20%

Full year 2024 earnings released: EPS: ₹1.11 (vs ₹1.36 in FY 2023)

Vineet Laboratories Limited Announces Resignation of Satish Pandurang Samant as Executive Director

New minor risk - Share price stability

Vineet Laboratories Limited to Report Q4, 2024 Results on May 29, 2024

Investor sentiment improves as stock rises 15%

Third quarter 2024 earnings released: ₹2.22 loss per share (vs ₹1.51 profit in 3Q 2023)

Vineet Laboratories Limited to Report Q3, 2024 Results on Feb 12, 2024

Investor sentiment improves as stock rises 21%

Investor sentiment improves as stock rises 32%

Second quarter 2024 earnings released: EPS: ₹2.62 (vs ₹5.10 loss in 2Q 2023)

Vineet Laboratories Limited Announces Appointment of Mr. Rameshkumar Bandari as Company Secretary and Compliance Officer

Vineet Laboratories Limited to Report Q2, 2024 Results on Nov 10, 2023

Vineet Laboratories Limited Announces Resignation of Nirosha Ravikanti as Company Secretary / Compliance Officer of the Company

New minor risk - Share price stability

Vineet Laboratories Limited Appoints Mr. Satish Pandurang Samant as Chief Executive Officer

Vineet Laboratories Limited Appoints Mr. Satish Pandurang Samant as Chief Executive Officer

Vineet Laboratories Limited, Annual General Meeting, Sep 28, 2023

Vineet Laboratories Limited Announces Board Changes

New major risk - Revenue and earnings growth

First quarter 2024 earnings released: ₹1.36 loss per share (vs ₹1.10 profit in 1Q 2023)

Investor sentiment improves as stock rises 21%

Vineet Laboratories Limited to Report Q1, 2024 Results on Aug 12, 2023

Full year 2023 earnings released: EPS: ₹1.36 (vs ₹7.20 in FY 2022)

Vineet Laboratories Limited to Report Q4, 2023 Results on May 29, 2023

Investor sentiment improves as stock rises 24%

MD & Director recently bought ₹333k worth of stock

MD & Director recently bought ₹416k worth of stock

MD & Director recently bought ₹868k worth of stock

MD & Director recently bought ₹430k worth of stock

Investor sentiment deteriorates as stock falls 16%

Third quarter 2023 earnings released: EPS: ₹1.51 (vs ₹3.52 in 3Q 2022)

Vineet Laboratories Limited to Report Q3, 2023 Results on Feb 14, 2023

Investor sentiment improved over the past week

Second quarter 2023 earnings released: ₹5.10 loss per share (vs ₹3.52 profit in 2Q 2022)

High number of new and inexperienced directors

Vineet Laboratories Limited Approves Change the Designation of Kandula Murali Mohan from Non- Executive Director to Whole Time Director

Vineet Laboratories Limited, Annual General Meeting, Sep 28, 2022

First quarter 2023 earnings released: EPS: ₹1.10 (vs ₹2.18 in 1Q 2022)

Vineet Laboratories Limited Appoints Mrs. Yerukalapudi Hari Priya as Additional Independent Director (Non-Executive)

Vineet Laboratories Limited to Report Q1, 2023 Results on Jul 29, 2022

Vineet Laboratories Limited Announces Resignation of Thotakura Uma Sangeetha as Independent Director

Investor sentiment improved over the past week

Vineet Laboratories Limited Recommends Final Dividend for the Financial Year Ended March 31, 2022

Full year 2022 earnings released: EPS: ₹7.16 (vs ₹1.93 in FY 2021)

Vineet Laboratories Limited to Report Q4, 2022 Results on May 28, 2022

Investor sentiment improved over the past week

High number of new and inexperienced directors

Investor sentiment improved over the past week

High number of new and inexperienced directors

Investor sentiment deteriorated over the past week

CEO

Yönetim Kurulu Üyeleri

Ortalama Görev Süresi

Ortalama Yaş